SARcode Bioscience Announces Acquisition by Shire US Holdings
SARcode Bioscience, Inc., an ophthalmic biopharmaceutical
company, announced today that it will be acquired
by Shire US Holdings Inc., a global specialty biopharmaceutical
company focused on enabling people with lifealtering
conditions to lead better lives. SARcode's lead
program, lifitegrast ophthalmic solution, is cu...